Logo of the International Congress on Porphyrins and Porphyrias 2015

International Congress on Porphyrins and Porphyrias

Sept 14th – Sept 16th 2015, Düsseldorf, Germany

The Content

20. A randomized, placebo controlled, phase 1 study of ALN-AS1, an Investigational RNAi therapeutic targeting ALAS1.

Kommentare sind geschlossen.